Cataract Surgery Clinical Trial
Official title:
A Prospective Multicenter Study To Assess The Clinical Outcomes Of Current Phacoemulsification Approach To Cataract Extraction Versus The Micor System Device Using Low Energy Lens Extraction In Patients Undergoing Cataract Surgery
The purpose of this research study is to evaluate the clinical outcomes of current phacoemulsification approaches to cataract extraction involving high-frequency thermogenic energy versus the use of the MICOR System device using low-energy segment removal with a micro-interventional irrigation/aspiration port to evacuate the lens in subjects undergoing routine cataract surgery.
This is prospective, multicenter, 3-arm study designed to provide longitudinal, observational, clinical outcome data for the use of traditional phacoemulsification for subjects undergoing cataract surgery versus the MICOR System device used to evacuate the lens prior to intraocular lens insertion and cataract surgery. Only FDA cleared phacoemulsification devices can be used per indications. Both eyes of the study subjects may be enrolled into the study; however, if only 1 eye is eligible for study participation, then the eligible eye of the subject may be enrolled. Up to 750 eyes will be enrolled into one of three study groups, up to 250 subjects per group, with a maximum of 10 study centers. The 3 arms of the study groups are as follows: - Group 1 Phaco subject cohort. - Group 2 MICOR System subject cohort, non-use of miLOOP. - Group 3 MICOR System subject cohort, use of miLOOP optional. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02573610 -
Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract Surgery
|
Phase 3 | |
Completed |
NCT02910362 -
Intra-surgical Evaluation of CATS Tonometer Prism and Abbott Medical Optics Versus Alcon Phacoemulsification Machines
|
N/A | |
Recruiting |
NCT01193504 -
Randomized, Masked Comparison of Bromfenac and Besifloxacin BID With Either Prednisolone BID or Loteprednol 0.5% BID for Prevention of Retinal Thickening and CME Following Phacoemulsification
|
Phase 4 | |
Completed |
NCT01199510 -
Efficacy Evaluation of SYSTANE® ULTRA in Patients Scheduled for Cataract Surgery
|
Phase 4 | |
Completed |
NCT01455233 -
2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery
|
Phase 4 | |
Completed |
NCT04146961 -
The PanOptix Trifocal IOL: A Study of Patient Satisfaction, Visual Disturbances, and Uncorrected Visual Performance
|
||
Completed |
NCT00585975 -
Efficacy and Safety of Bromfenac Ophthalmic Solution
|
Phase 2 | |
Completed |
NCT00406913 -
Prophylaxis Prior to Cataract Surgery Conjunctival Flora and Optimal Ocular Sterilization Technique Prior to Cataract Surgery
|
N/A | |
Not yet recruiting |
NCT04131335 -
Use of Prophylactic Lubricating Drops After Cataract Surgery
|
N/A | |
Recruiting |
NCT05331690 -
Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN)
|
Phase 4 | |
Withdrawn |
NCT04563559 -
PREFERENTIAL Study
|
Phase 2/Phase 3 | |
Completed |
NCT04732351 -
Evaluation of the Active Sentry System During Cataract Surgery With the Centurion Phacoemulsifier
|
||
Completed |
NCT02128113 -
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
|
Phase 2 | |
Completed |
NCT03873454 -
The Effects of Music on Perioperative Outcomes in Cataract Surgery
|
N/A | |
Completed |
NCT04769856 -
Impact of Non-fasting on Anxiety in Cataract Surgery
|
N/A | |
Withdrawn |
NCT00604305 -
Comperative Trial Between an Accommodative Iol and Monofocal Iol
|
N/A | |
Completed |
NCT05925894 -
Efficacy Mydrane ® for Cataract Surgery in Patients With Concomitant Primary Open Angle Glaucoma.
|
N/A | |
Not yet recruiting |
NCT06136780 -
Impact of Free Reading Glasses on Work and Visual Function Following Cataract Surgery in Honduras
|
N/A | |
Completed |
NCT04633954 -
Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract Surgery
|
N/A | |
Completed |
NCT03644875 -
Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
|